These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22304659)

  • 1. Fast and pH-dependent release of domperidone from orally disintegrating tablets.
    Assaf SM; Qandil AM; Al-Ani EA
    Pharm Dev Technol; 2013; 18(4):897-905. PubMed ID: 22304659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
    Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
    Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing dissolution of domperidone by spray-drying: effect of different storage conditions on stability.
    Lee JH; Kim MJ; Yang J; Kim KH; Kim HM; Lee SJ; Lee D; Khang G
    Ther Deliv; 2014 Mar; 5(3):265-75. PubMed ID: 24592953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gum Ghatti--a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone.
    Gurpreetarora ; Malik K; Rana V; Singh I
    Acta Pol Pharm; 2012; 69(4):725-37. PubMed ID: 22876617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR; Gonugunta CS; Veerareddy PR
    PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and development of orodispersible sustained release tablet of domperidone.
    Patil HG; Tiwari RV; Repka MA; Singh KK
    Drug Dev Ind Pharm; 2016; 42(6):906-15. PubMed ID: 26472165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmucosal delivery of domperidone from bilayered buccal patches: in vitro, ex vivo and in vivo characterization.
    Palem CR; Gannu R; Doodipala N; Yamsani VV; Yamsani MR
    Arch Pharm Res; 2011 Oct; 34(10):1701-10. PubMed ID: 22076770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats.
    Tawfeek HM; Faisal W; Soliman GM
    Pharm Dev Technol; 2018 Jun; 23(5):496-503. PubMed ID: 28489472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.
    Daraghmeh N; Chowdhry BZ; Leharne SA; Al Omari MM; Badwan AA
    Mar Drugs; 2015 Mar; 13(4):1739-64. PubMed ID: 25830680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on the Potential Application of Na-Attapulgite as an Excipient in Domperidone Sustained-Release Tablets.
    Xiao Y; Zheng H; Du M; Zhang Z
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of domperidone solid dispersions.
    Essa EA; Balata GF
    Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
    Cantor SL; Khan MA; Gupta A
    Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability.
    Desai S; Poddar A; Sawant K
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():826-34. PubMed ID: 26478377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.